Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LVIII.b

Path: Eosinophilic pneumonia (subacute or acute) (see also Ic)

Publications

Mochizuka Y, Fujisawa T, Inoue Y, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T

Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report.

Respiratory medicine case reports 2022;37;101632 — 2022 — 101632

Nasim F, Paul JA, Boland-Froemming J, Wylam ME

Sulfa-induced acute eosinophilic pneumonia.

Respiratory medicine case reports 2021;34;101496 — 2021 — 101496